SELLAS Life Sciences SLS
NASDAQ SLS
$12.15 +0.64 (+5.56%)
As of: Sep 30, 2026 · 12:10 PM EDT

SELLAS Life Sciences (SLS) Revenue (2012 - 2022)

Updated

SELLAS Life Sciences (SLS) posted Revenue of $1 million for FY2022, down 86.8% from $7.6 million in FY2021.

Analysis

SELLAS Life Sciences (SLS) Revenue (2012 - 2022) Analysis & Trends

Since FY2013, SELLAS Life Sciences has reported Revenue for 5 years.

  • The FY2022 figure stands as the lowest annual Revenue in data going back to FY2013.
  • Business Quant data shows SLS's Revenue at $7.6 million in FY2021 (+300.0%) and $1.9 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 SELLAS Life Sciences 2.34 Bn 2.34 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 1.00 Mn
Jun 30, 2021 1.90 Mn
Mar 31, 2021 5.70 Mn
Dec 31, 2020 1.90 Mn
Jun 30, 2015 3.38 Mn
Mar 31, 2015 2.75 Mn
Dec 31, 2014 3.20 Mn
Sep 30, 2014 1.62 Mn
Jun 30, 2014 2.33 Mn
Mar 31, 2014 2.17 Mn
Dec 31, 2013 3.20 Mn
Sep 30, 2013 1.62 Mn
Jun 30, 2013 2.33 Mn
Mar 31, 2013 2.17 Mn
Dec 31, 2012 -1.17 Mn
Sep 30, 2012 1.17 Mn
API Access

SELLAS Life Sciences Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=SLS&period=max&api_key=YOUR_API_KEY